» Articles » PMID: 25639751

Famine Versus Feast: Understanding the Metabolism of Tumors in Vivo

Overview
Specialty Biochemistry
Date 2015 Feb 3
PMID 25639751
Citations 103
Authors
Affiliations
Soon will be listed here.
Abstract

To fuel unregulated proliferation, cancer cells alter metabolism to support macromolecule biosynthesis. Cell culture studies have revealed how different oncogenic mutations and nutrients impact metabolism. Glucose and glutamine are the primary fuels used in vitro; however, recent studies have suggested that utilization of other amino acids as well as lipids and protein can also be important to cancer cells. Early investigations of tumor metabolism are translating these findings to the biology of whole tumors and suggest that additional complexity exists beyond nutrient availability alone in vivo. Whole-body metabolism and tumor heterogeneity also influence the metabolism of tumor cells, and successful targeting of metabolism for cancer therapy will require an understanding of tumor metabolism in vivo.

Citing Articles

Mitochondrial Dysfunction and Metabolic Disturbances Induced by Viral Infections.

Perez S, Gooz M, Maldonado E Cells. 2024; 13(21.

PMID: 39513896 PMC: 11545457. DOI: 10.3390/cells13211789.


Glutamine transporters as effective targets in digestive system malignant tumor treatment.

Chu F, Tong K, Gu X, Bao M, Chen Y, Wang B Oncol Res. 2024; 32(10):1661-1671.

PMID: 39308523 PMC: 11413814. DOI: 10.32604/or.2024.048287.


HIF1α-dependent uncoupling of glycolysis suppresses tumor cell proliferation.

Urrutia A, Mesa-Ciller C, Guajardo-Grence A, Alkan H, Soro-Arnaiz I, Vandekeere A Cell Rep. 2024; 43(4):114103.

PMID: 38607920 PMC: 11063627. DOI: 10.1016/j.celrep.2024.114103.


SLC38A2 promotes cell proliferation and invasion by promoting glutamine metabolism in adenomyosis.

Wu K, Gong W, Hu J, Duan Y, Ke H, Chen L Exp Ther Med. 2024; 27(5):218.

PMID: 38590564 PMC: 11000443. DOI: 10.3892/etm.2024.12506.


Distinguishing benign and malignant thyroid nodules using plasma trimethylamine N-oxide, carnitine, choline and betaine.

Shi L, Guo M, Shi C, Gao G, Xu X, Zhang C J Cancer Res Clin Oncol. 2024; 150(3):142.

PMID: 38503944 PMC: 10951046. DOI: 10.1007/s00432-024-05666-w.


References
1.
Inculet R, Stein T, Peacock J, Leskiw M, Maher M, Gorschboth C . Altered leucine metabolism in noncachectic sarcoma patients. Cancer Res. 1987; 47(17):4746-9. View

2.
Eagle H . The specific amino acid requirements of a human carcinoma cell (Stain HeLa) in tissue culture. J Exp Med. 1955; 102(1):37-48. PMC: 2136494. DOI: 10.1084/jem.102.1.37. View

3.
Prabhu A, Sarcar B, Kahali S, Yuan Z, Johnson J, Adam K . Cysteine catabolism: a novel metabolic pathway contributing to glioblastoma growth. Cancer Res. 2013; 74(3):787-96. PMC: 5726254. DOI: 10.1158/0008-5472.CAN-13-1423. View

4.
Maddocks O, Vousden K . Metabolic regulation by p53. J Mol Med (Berl). 2011; 89(3):237-45. PMC: 3043245. DOI: 10.1007/s00109-011-0735-5. View

5.
Dolfi S, Chan L, Qiu J, Tedeschi P, Bertino J, Hirshfield K . The metabolic demands of cancer cells are coupled to their size and protein synthesis rates. Cancer Metab. 2013; 1(1):20. PMC: 4178206. DOI: 10.1186/2049-3002-1-20. View